Prime Medicine (PRME) Deferred Taxes (2021 - 2024)

Prime Medicine posted quarterly Deferred Taxes of -$134000.0 for Q2 2024, down 532.26% year-on-year from $31000.0 in Q3 2023, and down 200.0% on a QoQ basis from $134000.0 in Q1 2024.

Prime Medicine (PRME) has 4 years of Deferred Taxes data on file, last reported at -$134000.0 in Q2 2024.

  • For the quarter ending Q2 2024, Deferred Taxes fell 532.26% year-over-year to -$134000.0; the trailing twelve-month figure through Mar 2025 stood at -$134000.0 (down 335.09% YoY), and the FY2023 full-year result was -$279000.0, up 71.06% from the prior year.
  • Deferred Taxes for Q2 2024 stood at -$134000.0, down from $134000.0 in the prior quarter.
  • Across five years, Deferred Taxes topped out at $1.2 million in Q4 2021 and bottomed at -$532000.0 in Q1 2022.
  • The 4-year median for Deferred Taxes is -$121000.0 (2023), against an average of $0.0.
  • Peak annual rise in Deferred Taxes reached 166.34% in 2024, while the deepest fall reached 532.26% in 2024.
  • A 4-year view of Deferred Taxes shows it stood at $1.2 million in 2021, then plunged by 116.25% to -$202000.0 in 2022, then jumped by 46.53% to -$108000.0 in 2023, then slipped by 24.07% to -$134000.0 in 2024.
  • The last three Deferred Taxes figures came in at -$134000.0 (Q2 2024), $134000.0 (Q1 2024), and -$108000.0 (Q3 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -859,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -65.30 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 96.00 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 9.31 Mn
10 Prime Medicine 601.24 Mn 601.24 Mn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2024 -134,000.00
Mar 31, 2024 134,000.00
Sep 30, 2023 -108,000.00
Jun 30, 2023 31,000.00
Mar 31, 2023 -202,000.00
Dec 31, 2022 -202,000.00
Sep 30, 2022 212,000.00
Jun 30, 2022 -442,000.00
Mar 31, 2022 -532,000.00
Dec 31, 2021 1.24 Mn